Karsten E. Weber
0000-0003-0001-2135
Publication & Citation Trends
Publications
0 total
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer
Cited by 0
Semantic Scholar
Abstract P1-09-06: Evaluation of proliferation biomarker serum thymidine kinase activity and prediction of early relapse in HR positive HER2 negative high risk early breast cancer: Analysis from the PENELOPE-B trial
Cited by 0
Semantic Scholar
Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping. OA
Cited by 16
Semantic Scholar
Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies.
Cited by 0
Semantic Scholar
Tumor-infiltrating lymphocytes in breast cancer through artificial intelligence: biomarker analysis from the results of the TIGER challenge OA
Cited by 5
Semantic Scholar
BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2– Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis
Cited by 2
Semantic Scholar
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer OA
Cited by 10
Semantic Scholar
Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple‐negative breast cancer patients OA
Cited by 0
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(59)
HER2/EGFR in Cancer Research
(53)
Cancer Immunotherapy and Biomarkers
(43)
Cancer Genomics and Diagnostics
(41)
Cancer Treatment and Pharmacology
(36)
Affiliations
Goethe University Frankfurt
Siemens (Germany)
Universität Hamburg
Friedrich-Alexander-Universität Erlangen-Nürnberg
Johannes Gutenberg University Mainz